EPI

Essa Pharma (EPI)

Essa Pharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:TSXV:EPI

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2021/02/26	08 : 33	PR Newswire (Canada)	ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders	TSXV:EPI	Essa Pharma Inc
2021/01/13	21 : 00	PR Newswire (Canada)	ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castr...	TSXV:EPI	Essa Pharma Inc
2020/12/16	07 : 01	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...	TSXV:EPI	Essa Pharma Inc
2020/11/25	21 : 00	PR Newswire (Canada)	ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference	TSXV:EPI	Essa Pharma Inc
2020/10/27	06 : 01	PR Newswire (Canada)	ESSA Pharma Inc. Announces Delisting from the TSX-V	TSXV:EPI	Essa Pharma Inc
2020/10/25	08 : 18	PR Newswire (Canada)	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium	TSXV:EPI	Essa Pharma Inc
2020/10/19	20 : 00	PR Newswire (Canada)	ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia	TSXV:EPI	Essa Pharma Inc
2020/09/21	20 : 00	PR Newswire (Canada)	ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit	TSXV:EPI	Essa Pharma Inc
2020/09/18	06 : 05	PR Newswire (Canada)	ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020	TSXV:EPI	Essa Pharma Inc
2020/09/14	20 : 00	PR Newswire (Canada)	ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resist...	TSXV:EPI	Essa Pharma Inc
2020/09/10	20 : 00	PR Newswire (Canada)	ESSA Pharma to Participate in Multiple Upcoming Investor Conferences	TSXV:EPI	Essa Pharma Inc
2020/08/07	09 : 00	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2020	TSXV:EPI	Essa Pharma Inc
2020/07/31	23 : 16	PR Newswire (Canada)	ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000	TSXV:EPI	Essa Pharma Inc
2020/07/29	22 : 07	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - EPI	TSXV:EPI	Essa Pharma Inc
2020/07/29	22 : 05	PR Newswire (Canada)	IIROC Trading Resumption - EPI	TSXV:EPI	Essa Pharma Inc
2020/07/29	10 : 18	PR Newswire (Canada)	ESSA Pharma Announces Pricing of Public Offering of Common Shares	TSXV:EPI	Essa Pharma Inc
2020/07/29	05 : 03	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - EPI	TSXV:EPI	Essa Pharma Inc
2020/07/29	05 : 01	PR Newswire (Canada)	ESSA Pharma Announces Proposed Public Offering of Common Shares	TSXV:EPI	Essa Pharma Inc
2020/07/29	05 : 01	PR Newswire (Canada)	IIROC Trading Halt - EPI	TSXV:EPI	Essa Pharma Inc
2020/07/15	20 : 00	PR Newswire (Canada)	ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostra...	TSXV:EPI	Essa Pharma Inc
2020/06/22	20 : 30	PR Newswire (Canada)	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Me...	TSXV:EPI	Essa Pharma Inc
2020/05/27	20 : 00	PR Newswire (Canada)	ESSA Pharma to Present at Jefferies Virtual Healthcare Conference	TSXV:EPI	Essa Pharma Inc
2020/05/15	20 : 30	PR Newswire (Canada)	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting	TSXV:EPI	Essa Pharma Inc
2020/05/08	06 : 05	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020	TSXV:EPI	Essa Pharma Inc
2020/05/01	06 : 45	PR Newswire (Canada)	ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate Cancer	TSXV:EPI	Essa Pharma Inc
2020/04/14	07 : 08	PR Newswire (Canada)	ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement	TSXV:EPI	Essa Pharma Inc
2020/03/31	20 : 00	PR Newswire (Canada)	ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update	TSXV:EPI	Essa Pharma Inc
2020/02/28	09 : 51	PR Newswire (Canada)	ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders	TSXV:EPI	Essa Pharma Inc
2020/02/14	07 : 48	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019	TSXV:EPI	Essa Pharma Inc
2020/02/11	08 : 15	PR Newswire (Canada)	ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia	TSXV:EPI	Essa Pharma Inc